Teijin Ltd. announced that Norio Kamei, Representative Director of the Board, Executive Vice President Managing GM, Advanced Fibers & Composites Business Group, Electric Materials & Performance Polymer Products Business Group and Raw Materials, Polymers & Procurement Division has been changed to Member of the Board Advisor; Takashi Takahashi, Member of the Board, Senior Executive Officer Chief Science and Technology Officer Director, Iwakuni Factory, Matsuyama Factory and Mihara Factor Supervisor of Safety Control has been changed to Member of the Board Advisor, Supervisor of Safety Control; Yoshio Fukuda, Member of the Board, Senior Executive Officer General Manager, Electric Materials & Performance Polymer Products Business Group has been changed to Member of the Board, Senior Executive Officer General Manager, Electric Materials & Performance Polymer Products Business Group General Manager, Films Business Unit; Kentaro Arao, Teijin Group Senior Executive Officer, Chief Marketing Officer, Director, BRICs Business has been changed to General Manager, New Business Development Business Unit; Yo Goto, Teijin Group Executive Officer, Chief Engineering Officer, Deputy Chief Social Responsibility Officer has been changed to Director, Iwakuni Factory, Matsuyama Factory and Mihara Factory; Masaya Endo, Teijin Group Executive Officer General Manager, High Performance Fibers Business Unit has been changed to Teijin Group Executive Officer General Manager, Advanced Fibers & Composites Business Group General Manager, High Performance Fibers Business Unit; Kazuhiro Yamamoto, Teijin Group Corporate Officer, Corporate Strategy Officer has been changed to Teijin Group Executive Officer CFO, General Manager, Accounting, Finance & Procurement Division; Executive Staff, Tejin Pharma Limited has been changed to Teijin Group Executive Officer Senior Corporate Project Officer; Yoshihisa Sonobe, Teijin Group Corporate Officer CFO, General Manager, Accounting, Finance & IR Division has been changed to Teijin Group Corporate Officer, Corporate Strategy Officer; Kimihiko Sato, Teijin Group Corporate Officer, Deputy Chief Science and Technology Officer (for manufacturing and technology), General Manager, Corporate Strategic Technology Department has been changed to Teijin Group Corporate Officer, Deputy General Manager, Technology Center (for Manufacturing and Technology) General Manager, Corporate Strategic Technology Department; Takashi Kamimura, General Manager, New Healthcare Business Development Project has been changed to Teijin Group Corporate Officer Deputy General Manager, Technology Center (for Research & Development) General Manager, Technology Innovation Center; Hideko Mihara, Teijin Group Executive Officer Deputy Chief Science and Technology Officer (for Intellectual property) General Manager, Intellectual Property Department has been changed to Teijin Group Corporate Officer Deputy General Manager, Technology Center (for Intellectual property); Taizo Makari, Teijin Group Corporate Officer Teijin Group Chief Representative in Europe President, Teijin Holdings Netherlands B.V. has been changed to Teijin Group Corporate Officer General Manager, Engineering Division Deputy Chief Social Responsibility Officer (for Disaster Prevention); Toshiya Koyama, Teijin Group Corporate Officer General Manager, New Materials Business Development Department President, TEIJIN ELECTRONICS KOREA Co.Ltd. has been changed to Teijin Group Corporate Officer General Manager, Battery Materials Business Development Project; Takashi Shiro, Teijin Group Corporate Officer Director, Integrative Technology Research Institute has been changed to Teijin Group Corporate Officer General Manager, Erectronics Materials Development Project; Noriaki Endo, Director, Teijin Pharma Limited (General Manager, Compliance Division) has been changed to Teijin Group Corporate Officer Director, Teijin Pharma Limited (General Manager, Compliance Division); Nobuyuki Takakura, Executive Staff has been changed to Teijin Group Corporate Officer Deputy Chief Social Responsibility Officer (for Special Assignment); Hiroyuki Umetani, General Manager, Research, Development & Production Division has been changed to Teijin Group Corporate Officer Deputy General Manager, Technology Center General Manager, Intellectual Property Department; Kazuo Imose, Teijin Group Corporate Officer General Manager, New Business Development Group General Manager, New Business Incubation & Development Division has been changed to Executive Staff for Technology, Deputy General Manager, New Business Development, Business Unit (for New Healthcare Business), General Manager, Technology Alliance Development Department; Shunichi Matsumura, Teijin Group Corporate Officer Deputy Chief Science and Technology Officer (for Research & Development); General Manager, Corporate Research & Technology Division has been changed to Advisor for Technology; Tamotsu Koyama, Teijin Group Corporate Officer General Manager, CSR and Compliance Department has been changed to Executive Staff for Technology, Deputy Chief Social Responsibility Officer; Yasuhiko Saito, Teijin Group Corporate Officer General Manager, Raw Materials, Polymers & Procurement Division General Manager, Raw Materials and Polymers Division has been changed to General Manager, Raw Materials and Polymers Division; Kiyoshi Bannai, General Manager, Technology Alliance Development Department has been changed to Executive Staff for Technology; Tomohiro Ohta, Director, Tejin Pharma Limited (General Manager, Marketing Division Manager, Pharmaceutical of Respiratory Diseases Scientific Promotion Section) has been changed to Deputy General Manager, New Business Development Business Unit (for Healthcare); Tetsuya Yano, General Manager, Compliance Group has been changed to General Manager, CSR and Compliance Department; Tadashi Sakata, General Manager, Engineering Fibers Department has been changed to President, TEIJIN CORPORATION (THAILAND) LIMITED President, Teijin Polyester (Thailand) Limited President, TEIJIN (THAILAND) LIMITED; Hiroshi Kawabata, General Manager, Pharmaceutical Products Research Laboratories­ Teijin Pharma Limited has been changed to General Manager, New Healthcare Business Development Project; Yuji Maruyama, Teijin Group Executive Officer General Manager, Films Business Unit has been scheduled to retire; and Kazuyuki Sakai, Advisor for Technology Unit has been scheduled to retire. These changes are effective from April 1, 2014.